Back to Search Start Over

Oral Coadministration of Fluconazole with Tramadol Markedly Increases Plasma and Urine Concentrations of Tramadol and the O- Desmethyltramadol Metabolite in Healthy Dogs.

Authors :
Perez Jimenez TE
Kukanich B
Joo H
Mealey KL
Grubb TL
Greene SA
Court MH
Source :
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2019 Jan; Vol. 47 (1), pp. 15-25. Date of Electronic Publication: 2018 Oct 26.
Publication Year :
2019

Abstract

Tramadol is used frequently in the management of mild to moderate pain conditions in dogs. This use is controversial because multiple reports in treated dogs demonstrate very low plasma concentrations of O -desmethyltramadol (M1), the active metabolite. The objective of this study was to identify a drug that could be coadministered with tramadol to increase plasma M1 concentrations, thereby enhancing analgesic efficacy. In vitro studies were initially conducted to identify a compound that inhibited tramadol metabolism to N -desmethyltramadol (M2) and M1 metabolism to N , O -didesmethyltramadol (M5) without reducing tramadol metabolism to M1. A randomized crossover drug-drug interaction study was then conducted by administering this inhibitor or placebo with tramadol to 12 dogs. Blood and urine samples were collected to measure tramadol, tramadol metabolites, and inhibitor concentrations. After screening 86 compounds, fluconazole was the only drug found to inhibit M2 and M5 formation potently without reducing M1 formation. Four hours after tramadol administration to fluconazole-treated dogs, there were marked statistically significant ( P < 0.001; Wilcoxon signed-rank test) increases in plasma tramadol (31-fold higher) and M1 (39-fold higher) concentrations when compared with placebo-treated dogs. Conversely, plasma M2 and M5 concentrations were significantly lower (11-fold and 3-fold, respectively; P < 0.01) in fluconazole-treated dogs. Metabolite concentrations in urine followed a similar pattern. This is the first study to demonstrate a potentially beneficial drug-drug interaction in dogs through enhancing plasma tramadol and M1 concentrations. Future studies are needed to determine whether adding fluconazole can enhance the analgesic efficacy of tramadol in healthy dogs and clinical patients experiencing pain.<br /> (Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.)

Details

Language :
English
ISSN :
1521-009X
Volume :
47
Issue :
1
Database :
MEDLINE
Journal :
Drug metabolism and disposition: the biological fate of chemicals
Publication Type :
Academic Journal
Accession number :
30366901
Full Text :
https://doi.org/10.1124/dmd.118.083444